With new markets opening throughout the developing
world, an ageing population in established markets, governments and
employers striving to reign in healthcare expenditure, and so many
blockbuster drugs edging toward patent expiry, the generic industry
offers phenomenal opportunities.
However, generic dose prices are falling in many countries, squeezing
margins. The number of players is increasing, while low-cost active
ingredients from India and China further depress prices.
So how do you keep ahead of your competitors? How do you chase down the
drugs to target, source APIs, and identify licensing and acquisitioning
opportunities?
We track, monitor and expertly analyze ongoing developments in thousands of
launched products and companies operating in the global pharmaceutical
market.
By incorporating the unique strategic intelligence and powerful competitive
analysis that is only available from Thomson Scientific, we could ensure
you’ll be first to find the drug, first to find the niche, first to
make the deal, and first to get to market.
If you’re an innovator, we can give you up to seven years’
advance warning of patent challenges and attempts at circumvention. Our
powerful competitive intelligence and analytical tools can help you
identify, assess and track the earliest signs of generic competition.
Further information
|
